Biomarker-based early detection of epithelial ovarian cancer based on a five-protein signature in patient’s plasma – a prospective trial

被引：0
|
作者：
A. Hasenburg
D. Eichkorn
F. Vosshagen
E. Obermayr
A. Geroldinger
R. Zeillinger
M. Bossart
机构：
[1] University Medical Center,Department of Obstetrics and Gynecology
[2] Department of Obstetrics and Gynecology,Department of Anesthesiology
[3] Schwarzwald-Baar Clinics,Department of Obstetrics and Gynecology
[4] Ortenau Clinics,Section for Clinical Biometrics, Center for Medical Statistics, Informatics and Intelligent Systems
[5] Medical University of Vienna,Department of Obstetrics and Gynecology
[6] Medical University of Vienna,undefined
[7] University Medical Center,undefined
来源：
BMC Cancer | / 21卷
关键词：
Ovarian cancer; Biomarker; Protein panel; CA125; Liquid biopsy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 46 条
  • [41] Effects of an interactive mHealth innovation for early detection of patient-reported symptom distress with focus on participatory care: protocol for a study based on prospective, randomised, controlled trials in patients with prostate and breast cancer
    Ann Langius-Eklöf
    Marie-Therése Crafoord
    Mats Christiansen
    Maria Fjell
    Kay Sundberg
    BMC Cancer, 17
  • [42] A prospective randomized controlled trial of ATP-based tumor chemosensitivity assay (ATP-TCA) directed chemotherapy versus physician's choice in patients with recurrent platinum-resistant ovarian cancer.
    Cree, IA
    Kurbacher, CM
    Lamont, A
    Hindley, AC
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 457S - 457S
  • [43] Ultrasensitive bioassay of epitope of Mucin-16 protein (CA 125) in human plasma samples using a novel immunoassay based on silver conductive nano-ink: A new platform in early stage diagnosis of ovarian cancer and efficient management
    Jafari, Mohsen
    Hasanzadeh, Mohammad
    Solhi, Elham
    Hassanpour, Soodabeh
    Shadjou, Nasrin
    Mokhtarzadeh, Ahad
    Jouyban, Abolghasem
    Mahboob, Soltanali
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2019, 126 : 1255 - 1265
  • [44] Getting the MOST out of follow-up: a randomized controlled trial comparing 3 monthly nurse led follow-up via telehealth, including monitoring CA125 and patient reported outcomes using the MOST (Measure of Ovarian Symptoms and Treatment concerns) with routine clinic based or telehealth follow-up, after completion of first line chemotherapy in patients with epithelial ovarian cancer
    Cohen, Paul A.
    Webb, Penelope M.
    King, Madeleine
    Obermair, Andreas
    Gebski, Val
    Butow, Phyllis
    Morton, Rachael
    Lawson, Wanda
    Yates, Patsy
    Campbell, Rachel
    Meniawy, Tarek
    McMullen, Michelle
    Dean, Andrew
    Goh, Jeffrey
    McNally, Orla
    Mileshkin, Linda
    Beale, Philip
    Beach, Rhonda
    Hill, Jane
    Dixon, Cyril
    Hegarty, Sue
    Codde, Jim
    Ives, Angela
    Lee, Yeh Chen
    Brand, Alison
    Mellon, Anne
    Bilic, Sanela
    Black, Isobel
    Jeffares, Stephanie
    Friedlander, Michael
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2022, 32 (04) : 560 - 565
  • [45] Treatment stratification according to early response to Mega-CHOP (MC), based on CT and gallium 67 scan (G67S) with or without IFE salvage therapy and autologous stem cell transplant (ASCT) in patient with poor prognosis aggressive lymphoma (PPAL).: A preliminary report from a prospective GEL/TAMO trial
    Caballero, M
    Arranz, R
    Rodriguez, J
    Gutierrez, M
    Grande, C
    Gandarillas, M
    Albo, C
    Garzón, S
    Hernández, M
    Vela, JG
    Fernández, P
    Bello, J
    Amigo, M
    Conde, E
    ANNALS OF ONCOLOGY, 2005, 16 : 184 - 184
  • [46] Treatment stratification according to early response to mega-CHOP, based on CT and gallium 67 scan (G67S) with or without IFE salvage therapy followed by peripheral autologous stem cell transplant (PBSCT) in patient with poor prognosis aggressive lymphoma.: A preliminary report from a prospective GEL/TAMO trial.
    Conde, E
    Arranz, R
    Rodriguez, J
    Gutierrez, ML
    Grande, C
    Gandarillas, M
    Albo, C
    Bello, JL
    Garzón, S
    Hernández, MT
    García-Vela, JA
    Fernández, P
    Amigo, ML
    Caballero, D
    BLOOD, 2005, 106 (11) : 932A - 932A
12345